Ozempic 短缺将马来西亚作为非诊断性高峰的减重工具而受欢迎。 Ozempic shortage hits Malaysia as its popularity as a weight-loss tool among non-diabetics spikes.

Ozempic是一种糖尿病药物,在马来西亚供应短缺,因为它在非糖尿病患者中作为一种减重药物受到欢迎。 Ozempic, a diabetes medication, is in short supply in Malaysia due to its popularity as a weight-loss drug among non-diabetics. 需求激增导致药店出现短缺。 The surge in demand has led to shortages at pharmacies. 马来西亚药剂师协会主席Amrahi Buang警告潜在的副作用,包括低血糖,并警告不要在没有医疗监督的情况下使用该药物。 Malaysian Pharmacists Society president Amrahi Buang warns of potential side effects, including hypoglycemia, and cautions against using the drug without medical supervision. 分销商正在配给供应,以解决短缺问题。 Distributors are rationing supplies to address the shortage.